■ September 14, 2015　 " Information on corporate activities and funding for medical institutions" and "Information on corporate activities and funding for patient groups " for fiscal 2014 have been posted in "Transparency Initiatives" of "About Torii Pharmaceutical" . ■ September 02, 2015　 " The 124th Interim Report (PDF)" has been added to the "Report" of "To Shareholders and Investors " . ■ August 07, 2015　 " Preliminary results of domestic phase II / III clinical trials of TO-206 (sublingual tablet), a desensitizing therapy (allergen immunotherapy) for Japanese cedar pollinosis," was posted in the "Press Release" . Examination and treatment by a specialist I'm not afraid of gout! 5.25MB 1.3MB Self-management of hyperuricemia / gout 2.1MB 2.09MB Let's get started athlete's foot treatment 0.9MB Don't hesitate anymore Atopic dermatitis 1.6MB 6.5MB Message from the president Corporate mission / action declaration compliance Company Profile Business content More details Click here for details Financial highlights Sales structure and major product areas Financial statements Securities report Stock price information More details Click here for details Flash Player is required to view the eBook. If you don't have the Flash Player plugin installed on your computer, please use the link on the left.